Synthesis and anti-MRSA Activity of Novel Cephalosporin Derivatives
β Scribed by Stan V. D'Andrea; Daniel Bonner; Joanne J. Bronson; Junius Clark; Ken Denbleyker; Joan Fung-Tomc; Shelley E. Hoeft; Thomas W. Hudyma; John D. Matiskella; Raymond F. Miller; Peter F. Misco; Michael Pucci; Roman Sterzycki; Yuan Tsai; Yasutsuga Ueda; John A. Wichtowski; Janak Singh; Thomas P. Kissick; Jeffery T. North; Annie Pullockaran; Michael Humora; Brenda Boyhan; Truc Vu; Alan Fritz; J. Heikes; Rita Fox; Jollie D. Godfrey; Robert Perrone; Murray Kaplan; David Kronenthal; Richard H. Mueller
- Book ID
- 108370864
- Publisher
- Elsevier Science
- Year
- 2000
- Tongue
- French
- Weight
- 212 KB
- Volume
- 56
- Category
- Article
- ISSN
- 0040-4020
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Synthesis and Structure-Activity Relationship of C-3 Benzoyloxymethyl Cephalosporins Exhibiting anti-MRSA Activities. -The title compounds, e.g. (VIa)-(VIc), show excellent in vitro activity against methicillin resistant Staphylococcus aureus besides a good stability in human plasma (some yields not
Novel C(3) propenylamide and propenylsulfonamide cephalosporins have been synthesized and tested for their ability to inhibit the penicillin-binding protein 2' (PBP2') from Staphylococcus epidermidis and the growth of a panel of clinically relevant bacterial species, including methicillin-resistant